From Setback to Breakthrough: A CEO’s Journey to a First-in-Class Approval with Reenie McCarthy

Episode 5

0:00-36:51

In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Reenie McCarthy, the CEO of Mighty Therapeutics, formerly known as Stealth BioTherapeutics. Reenie shares her path from venture investor to biotech CEO and the years-long effort to develop and secure approval for a first-in-class therapy targeting mitochondrial dysfunction. She discusses the scientific, regulatory, and funding challenges of advancing a novel treatment through clinical development, as well as the critical role of patient advocacy and the lessons learned from setbacks that ultimately helped shape the company's success. The conversation also explores the future of mitochondrial medicine...

Publisher

Clinical Trialblazers

Link

clinical-trialblazers.simplecast.com/episodes/from-setback-to-breakthrough-a-ceos-journey-to-a-first-in-class-approval-with-reenie-mccarthy-9TSdSBMJ

Published

July 7, 2026

Duration

37 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Parexel

CT

Clinical Trialblazers

@clinicaltrialblazers

#ceosjourney #classapproval #reeniemccarthy #lifesciences #medicine

The Nile